BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 25791873)

  • 1. Using routinely collected data to stratify prostate cancer patients into phases of care in the United Kingdom: implications for resource allocation and the cancer survivorship programme.
    Yip K; McConnell H; Alonzi R; Maher J
    Br J Cancer; 2015 Apr; 112(9):1594-602. PubMed ID: 25791873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Projections of cancer prevalence by phase of care: a potential tool for planning future health service needs.
    Yu XQ; Clements M; O'Connell D
    J Cancer Surviv; 2013 Dec; 7(4):641-51. PubMed ID: 23921991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase of care prevalence for prostate cancer in New South Wales, Australia: A population-based modelling study.
    Yu XQ; Luo Q; Smith DP; Clements MS; Patel MI; O'Connell DL
    PLoS One; 2017; 12(2):e0171013. PubMed ID: 28178275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer prevalence in the UK: results from the EUROPREVAL study.
    Forman D; Stockton D; Møller H; Quinn M; Babb P; De Angelis R; Micheli A
    Ann Oncol; 2003 Apr; 14(4):648-54. PubMed ID: 12649115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating long-term patient-centered outcomes following prostate cancer treatment: findings from the Michigan Prostate Cancer Survivor study.
    Darwish-Yassine M; Berenji M; Wing D; Copeland G; Demers RY; Garlinghouse C; Fagerlin A; Newth GE; Northouse L; Holmes-Rovner M; Rovner D; Sims J; Wei JT
    J Cancer Surviv; 2014 Mar; 8(1):121-30. PubMed ID: 24214413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there a role for survivorship care plans in advanced cancer?
    Mayer DK; Green M; Check DK; Gerstel A; Chen RC; Asher G; Wheeler SB; Hanson LC; Rosenstein DL
    Support Care Cancer; 2015 Aug; 23(8):2225-30. PubMed ID: 25559037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Survivorship Care Plans and Planning on Breast, Colon, and Prostate Cancer Survivors in a Community Oncology Practice.
    Hua A; Sesto ME; Zhang X; Wassenaar TR; Tevaarwerk AJ
    J Cancer Educ; 2020 Apr; 35(2):249-255. PubMed ID: 30610655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer treatment and survivorship statistics, 2016.
    Miller KD; Siegel RL; Lin CC; Mariotto AB; Kramer JL; Rowland JH; Stein KD; Alteri R; Jemal A
    CA Cancer J Clin; 2016 Jul; 66(4):271-89. PubMed ID: 27253694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer survivors in the United States: prevalence across the survivorship trajectory and implications for care.
    de Moor JS; Mariotto AB; Parry C; Alfano CM; Padgett L; Kent EE; Forsythe L; Scoppa S; Hachey M; Rowland JH
    Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):561-70. PubMed ID: 23535024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer prevalence by phase of care: an indicator for assessing health service needs.
    Gigli A; Francisci S; Guzzinati S; Hall A; Hachey M; Scoppa S; Mariotto A
    Tumori; 2021 Aug; 107(4):311-317. PubMed ID: 33095121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Avoiding the 'survivorship abyss': Qualitative insights from 15-year prostate cancer survivors.
    Mazariego CG; Laidsaar-Powell R; Smith DP; Juraskova I
    Psychooncology; 2021 Oct; 30(10):1745-1755. PubMed ID: 34038008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The magnitude and characteristics of the population of cancer survivors: using population-based estimates of cancer prevalence to inform service planning for survivorship care.
    Sharp L; Deady S; Gallagher P; Molcho M; Pearce A; Alforque Thomas A; Timmons A; Comber H
    BMC Cancer; 2014 Oct; 14():767. PubMed ID: 25319534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in follow-up and preventive care for colorectal cancer survivors.
    Snyder CF; Earle CC; Herbert RJ; Neville BA; Blackford AL; Frick KD
    J Gen Intern Med; 2008 Mar; 23(3):254-9. PubMed ID: 18197456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global, Regional and National Burden of Prostate Cancer, 1990 to 2015: Results from the Global Burden of Disease Study 2015.
    Pishgar F; Ebrahimi H; Saeedi Moghaddam S; Fitzmaurice C; Amini E
    J Urol; 2018 May; 199(5):1224-1232. PubMed ID: 29129779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Categorising cancers to enable tailored care planning through a secondary analysis of cancer registration data in the UK.
    McConnell H; White R; Maher J
    BMJ Open; 2017 Nov; 7(11):e016797. PubMed ID: 29170285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Lost to Follow-up" Among Adult Cancer Survivors.
    Gill A; Gosain R; Bhandari S; Gosain R; Gill G; Abraham J; Miller K
    Am J Clin Oncol; 2018 Oct; 41(10):1024-1027. PubMed ID: 29028642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Italian cancer figures, report 2014: Prevalence and cure of cancer in Italy.
    AIRTUM Working Group
    Epidemiol Prev; 2014; 38(6 Suppl 1):1-122. PubMed ID: 25759295
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.